Essylimar contains a silymarin-phospholipid complex containing 30% of flavonolignans (calculated as silybin). It is used traditionally in the proposed indications and its effectiveness is based only on long-term use and experience.
Supportive in liver dysfunction.
1 tablet contains: 100 mg of silymarin-phospholipid complex with 30% of flavonolignans as silybin and 1.5% of phosphorus. The other ingredients (excipients) are: microcrystalline cellulose with 2% colloidal silica, croscarmellose sodium, hypromellose, macrogol 6000, titanium dioxide, indigo carmine lake (E132), quinoline yellow lake (E104).
Stabilizing and normalizing the function of liver cells, reducing the symptoms of liver failure.
Adults: the usual dose of the preparation is: 1 tablet 3 times a day in chronic diseases; in acute conditions: 2 tablets 3 times a day. The preparation should be taken after eating.
Hypersensitivity to any of the ingredients of the preparation. It is not recommended for use in children under 12 years of age. In adolescents under 18 years of age, the use is possible after prior consultation with a doctor.